| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Feb 3, 2025 | Altimmune, Inc. | Chief Scientific Officer | Sell | 26.3 | -3,642 | -1.36% | ✗ | $46.3K |
| Jan 25, 2025 | Jan 28, 2025 | Altimmune, Inc. | Chief Scientific Officer | Sell | 26.3 | -4,264 | -7.36% | ✗ | $29.8K |
| Feb 1, 2024 | Feb 5, 2024 | Altimmune, Inc. | Chief Scientific Officer | Sell | 26.3 | -4,131 | -4.92% | ✗ | $39.5K |
| Jan 30, 2024 | Feb 1, 2024 | Altimmune, Inc. | Chief Scientific Officer | Sell | 91.3 | +3,151 | 10.60% | ✗ | $26.5K |
| Feb 2, 2023 | Feb 6, 2023 | Altimmune, Inc. | Chief Scientific Officer | Sell | 26.3 | -2,375 | -10.68% | ✗ | $35.7K |
| Jan 31, 2023 | Feb 2, 2023 | Altimmune, Inc. | Chief Scientific Officer | Sell | 26.3 | -747 | -2.91% | ✗ | $30.1K |
| Jul 1, 2022 | Jul 5, 2022 | Altimmune, Inc. | Chief Scientific Officer | Sell | 7.5 | -37,164 | -58.82% | ✓ | $446K |
| Jun 29, 2022 | Jun 30, 2022 | Altimmune, Inc. | Chief Scientific Officer | Sell | 15.0 | -5,462 | -23.57% | ✓ | $65.5K |
| Jun 27, 2022 | Jun 28, 2022 | Altimmune, Inc. | Chief Scientific Officer | Sell | 7.5 | -37,352 | -67.83% | ✓ | $448.3K |
| Jan 31, 2022 | Feb 3, 2022 | Altimmune, Inc. | Chief Scientific Officer | Sell | 43.8 | -77 | -0.24% | ✗ | $17.4K |
| Jun 6, 2017 | Feb 23, 2018 | Altimmune, Inc. | Chief Scientific Officer | Buy | 90.0 | +449 | 100.00% | ✗ | $2K |